PUBLIC COMPANY
save$AUPHAurinia Pharmaceuticals Inc.
$AUPH17.27+6.80%Edmonton, Alberta, CAupdated 11h ago
community read0 votes
pipeline
3
marketed
1
phase 3
0
catalysts ytd
1
approvals ytd
0
recalls ytd
0
Pipeline(3)
pipeline depth3 products
1Phase 11Marketed1Unknown
Upcoming
no upcoming catalysts on record
Recent(90d)
earnings (1)
Active trials
Insider activity
source: SEC Form 4open-market buys + sells
routine RSU / option mechanics (6)
- Mar 6, 26tax coverKeenan Greg · SVP, Chief Medical Officer8,069 sh
- Mar 2, 26tax coverGreenleaf Peter · Chief Executive Officer100,890 sh
- Mar 2, 26tax coverDonley Matthew Maxwell · Chief Operating Officer40,761 sh
- Mar 2, 26tax coverMiller Joseph M · Chief Financial Officer37,511 sh
- Mar 2, 26tax coverRobertson Stephen P. · EVP, General Counsel36,525 sh
- Feb 27, 26grantDonley Matthew Maxwell · Chief Operating Officer97,256 sh
🐶 Hiring Signal
News
- ‘Greg, you’ve got to bring back this platform’: How LifeMine won over Gates and Bezos for $188M series EA little over a year ago, LifeMine Therapeutics laid off staff and put its fungus-based platform on ice to focus its dwindling resources on its lead asset. Now, the Massachusetts biotech is shaking…fiercebiotech · 15d ago
Data sources
last refreshed 21m ago
Found something off?
comments(0)
5-min edit window · permanent after that